Loading company…
Migrasome Therapeutic develops drug delivery platforms, medicines, and diagnostic products.
Migrasome Therapeutic develops engineered drug delivery platforms, migrasome-related medicines, and diagnostic products. Its work draws on migrasomes, membrane-bound structures produced during cell migration that can transport biological signals. Established in 2022, the company is based in Beijing, China. In July 2023, it raised over CNY 100 million in angel+ funding led by Zhongguancun Co-Innovative Fund Management, with Tsinghua Capital, Qingkong Tiancheng Asset Management, Qihang Capital, and BSTIG participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in